Genenta Science SpA ADR

Genenta Science SpA ADR ROCE

The Return on Capital Employed (ROCE) of Genenta Science SpA ADR (SAEN) as of Nov 22, 2026 is -29.04 %. In the previous year, Return on Capital Employed (ROCE) was -81.63 % — a change of -64.42% (higher).

ROCE

-29.04 %

YoY

-64.42%

Last updated:

In 2025, Genenta Science SpA ADR's return on capital employed (ROCE) was -29.04 %, a -64.42% increase from the -81.63 % ROCE in the previous year.

The Genenta Science SpA ADR ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2019
-24.18 USD
Jan 1, 2020
-34.33 USD
Jan 1, 2021
-15.26 USD
Jan 1, 2022
-34.64 USD
Jan 1, 2023
-56.41 USD
Jan 1, 2024
-81.63 USD
Jan 1, 2025
-29.04 USD
The Genenta Science SpA ADR ROCE history
YEARROCEYoY
-29.04 %-64.42%
-81.63 %+44.69%
-56.41 %+62.86%
-34.64 %+127.05%
-15.26 %-55.56%
-34.33 %+41.97%
-24.18 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genenta Science SpA ADR Stock analysis

What does Genenta Science SpA ADR do? Genenta Science S.p.A. generates value by developing hematopoietic stem cell gene therapies for solid tumors in Italy. The company focuses on its product Temferon, which is currently in Phase 1/2a clinical trials for the treatment of glioblastoma multiforme in patients with unmethylated MGMT gene promoter. Additionally, the firm is expanding the application of Temferon to other solid tumor indications. The business model relies on a proprietary biologic platform designed to deliver immunomodulatory molecules directly to tumors by infiltrating monocytes and macrophages. As a clinical-stage biotechnology company incorporated in 2014 and headquartered in Milan, Italy, Genenta Science S.p.A. utilizes this platform to advance its therapeutic pipeline and address unmet medical needs in oncology. Genenta Science SpA ADR is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Genenta Science SpA ADR's Return on Capital Employed (ROCE)

Genenta Science SpA ADR's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Genenta Science SpA ADR's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Genenta Science SpA ADR's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Genenta Science SpA ADR’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Genenta Science SpA ADR stock

Return on Capital Employed (ROCE) of Genenta Science SpA ADR is -29.04 % in 2025.

Return on Capital Employed (ROCE) of Genenta Science SpA ADR changed from -81.63 % to -29.04 %, representing a -64.42% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Genenta Science SpA ADR since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Genenta Science SpA ADR with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Genenta Science SpA ADR

All Key Metrics — Genenta Science SpA ADR